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Abstract
Background: Data on the incidence, seasonality and mortality associated with influenza in subtropical low and middle
income countries are limited. Prospective data from multiple years are needed to develop vaccine policy and treatment
guidelines, and improve pandemic preparedness.
Methods: During January 2005 through December 2008, we used an active, population-based surveillance system to
prospectively identify hospitalized pneumonia cases with influenza confirmed by reverse transcriptase–polymerase chain
reaction or cell culture in 20 hospitals in two provinces in Thailand. Age-specific incidence was calculated and extrapolated
to estimate national annual influenza pneumonia hospital admissions and in-hospital deaths.
Results: Influenza was identified in 1,346 (10.4%) of pneumonia patients of all ages, and 10 influenza pneumonia patients
died while in the hospital. 702 (52%) influenza pneumonia patients were less than 15 years of age. The average annual
incidence of influenza pneumonia was greatest in children less than 5 years of age (236 per 100,000) and in those age 75 or
older (375 per 100,000). During 2005, 2006 and 2008 influenza A virus detection among pneumonia cases peaked during
June through October. In 2007 a sharp increase was observed during the months of January through April. Influenza B virus
infections did not demonstrate a consistent seasonal pattern. Influenza pneumonia incidence was high in 2005, a year when
influenza A(H3N2) subtype virus strains predominated, low in 2006 when A(H1N1) viruses were more common, moderate in
2007 when H3N2 and influenza B co-predominated, and high again in 2008 when influenza B viruses were most common.
During 2005–2008, influenza pneumonia resulted in an estimated annual average 36,413 hospital admissions and 322 in-
hospital pneumonia deaths in Thailand.
Conclusion: Influenza virus infection is an important cause of hospitalized pneumonia in Thailand. Young children and the
elderly are most affected and in-hospital deaths are more common than previously appreciated. Influenza occurs year-
round and tends to follow a bimodal seasonal pattern with substantial variability. The disease burden varies significantly
from year to year. Our findings support a recent Thailand Ministry of Public Health (MOPH) decision to extend annual
influenza vaccination to older adults and suggest that children should also be targeted for routine vaccination.
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Introduction
Influenza is a common vaccine preventable viral infection that
can cause severe or fatal disease in the elderly, the very young and
those with underlying illness [1,2,3,4,5]. In temperate climates of
Europe and North America, wintertime seasonal influenza
epidemics often result in dramatic increases in hospitalization,
death and significant economic losses due to workplace absentee-
ism [4,6,7]. Much less is known about the burden of influenza
morbidity and mortality in tropical and subtropical countries [8,9].
Data from Hong Kong and Singapore suggest that influenza is
an important cause of illness with rates of hospitalization and
mortality comparable to that of the United States [10,11,12,13].
The contribution of influenza virus infection to pneumonia, the
leading cause of pediatric mortality, has also not been determined.
This question is particularly important for developing countries in
tropical and subtropical climates where most childhood pneumo-
nia occurs and where influenza has historically been perceived as a
mild or uncommon disease. Prospective, multi-year, population-
based data on laboratory-confirmed influenza infection are needed
to describe the disease burden and inform prevention and control
strategies during both interpandemic and pandemic periods.
Thailand is a middle-income country with a 2005 population of
65,112,652 million and a well-developed public health system[14].
PLoS ONE | www.plosone.org 1 November 2009 | Volume 4 | Issue 11 | e7776The climate is subtropical with monsoon rains during the months
of May to October. Since 2003, national pandemic planning and
an improved understanding of influenza epidemiology have
increased interest in influenza vaccination. A 2004 study by
Simmerman and colleagues concluded that influenza infection is
associated with substantial health care and social costs in
Thailand[15]. Since 2004, the Thailand Ministry of Public Health
(MOPH) has offered free influenza vaccination to approximately
400,000 health care workers each year. In 2007 this coverage was
extended to persons 65 years of age and older with underlying risk
factors and development began on a domestic influenza vaccine
production facility [16,17]. In 2000, 72,102 influenza vaccine
doses were distributed; 750,000 doses were distributed in 2006; 1.3
million doses were distributed in 2008, and approximately 2.4
million doses were distributed in the public and private sectors in
2009 [18,19]. While this increase in vaccine uptake is notable, in
2009 influenza vaccine coverage was less than 4% across the
national population The expansion of the influenza vaccination
program may have also improved Thailand’s ability to respond to
the 2009 H1N1 pandemic by expanding national immunization
program capacity and experience with seasonal vaccination
campaigns [20]. Additional data from multiple years are needed
to guide decisions on the expansion of influenza vaccination in
Thailand and neighboring countries. We describe the incidence,
seasonality and in-hospital mortality associated with hospitalized
influenza pneumonia from two provinces in Thailand during four
consecutive years and extrapolate our findings to provide national
estimates of disease burden.
Methods
We prospectively identified all hospitalized pneumonia patients
during January 2005 through December 2008 using an active,
population-based surveillance system carried out through collab-
oration between the Thailand MOPH and the U.S. Centers for
Disease Control and Prevention (CDC) in Sa Kaeo province in
eastern Thailand and Nakhon Phanom province in northeast
Thailand (Figure 1)[21,22] . Sa Kaeo (pop 526,432) and Nakhon
Phanom (pop 734,000) are rural provinces with age distributions
that are similar to the national population [23]. The 2007
population densities of Sa Kaeo and Nakhon Phanom were 75 and
126 persons per km
2 respectively, compared to 111 per km
2 for all
of Thailand outside of Bangkok. The same year among 76 Thai
provinces, Nakhon Phanom ranked 74
th with a per capita GDP of
$891 while Sa Kaeo ranked 50
th with a per capita GDP of $1,632
(national range $858–$30,457 USD) [24]. During 2008 the mean
daily temperature in Sa Kaeo province was 26.8 degrees Celsius
with 1602 mm of total rainfall. The daily mean temperature in
Nakhon Phanom was 25.4 degrees Celsius and 2786 mm of
rainfall was recorded. For comparison, Thailand’s mean daily
temperature was 26.9 degrees and an average of 914.7 mm of rain
fell during 2008 [25].
As part of a larger prospective study of pneumonia etiology,
patients with clinical pneumonia were enrolled from all 20
hospitals in both provinces [22,26]. A case of clinical pneumonia
was defined in patients with evidence of both acute infection
(either reported fever, reported chills, measured temperature
.38.2 or ,35uC, or an abnormal white blood cell count or
differential) and lower respiratory tract symptoms (abnormal
breath sounds, tachypnea, cough, sputum production, or dyspnea).
From January 1, 2005 to Dec 31, 2007 patients with clinical
pneumonia and a chest radiograph taken within 48 hours of
admission were eligible for enrollment. Chest radiographs were
later digitized and read by a panel of radiologists in Bangkok [27].
Beginning in January 2008, the requirement for a chest
radiograph for study enrollment was dropped. To limit study
costs and laboratory workload resulting from the expanded
eligibility criteria, every other patient with clinical pneumonia
was approached for enrollment (Figure 2).
Patients transferred from another hospital, readmitted within
three days from the same hospital, and newborn infants were
excluded to avoid recording nosocomial infections. Patients who
were readmitted and reenrolled within 14 days were excluded
from the analysis. A nasopharyngeal swab specimen was collected
within 48 hours of admission after informed written consent was
obtained. The specimen was frozen at 270 degrees Celsius until
tested at the Thai National Institute of Health (NIH) laboratory by
reverse transcriptase–polymerase chain reaction (RT-PCR) (2005–
2008) and cell culture (only during 2005) using Madine-Darby
Canine Kidney cells using procedures provided by the Centers for
Disease Control and Prevention, U.S.A. (Stephen Lindstrom,
personal communication). Specific protocols are available upon
request from CDC [28,29]. A systematic, blinded laboratory
quality control system was instituted to monitor diagnostic
accuracy in coordination with the influenza laboratories at the
US CDC in Atlanta, Georgia. Data were entered into a database
(Microsoft Access) and statistical analyses were conducted using
Microsoft Excel and SAS version 9.1 (Cary, NC).
The age-specific incidence of laboratory-confirmed influenza
pneumonia was calculated by dividing the total number of
influenza cases among enrolled patients in each age category by
the combined corresponding age-specific population of both
provinces and is hereafter referred to as the minimum incidence.
We then calculated age-specific incidence adjusted for patients
who were eligible but who were not enrolled by applying the same
rate of influenza positivity as measured in each age category in the
enrolled group. To account for the different eligibility criteria in
2008, we adjusted the age-specific influenza incidence among
those with a chest radiograph and multiplied by two to account for
the 50% sampling frame. We applied a chi squared test of
proportion to determine if study participants with or without a
chest radiograph were more likely to have influenza pneumonia
during 2008. Next, we estimated the number of influenza
pneumonia hospitalizations nationwide by applying the minimum
and adjusted incidence from the two study provinces to the Thai
population using 2006 national census figures. We used a similar
approach for in-hospital mortality. We grouped these relatively
rare fatal events into three age categories (,15, 15–50, .50) and
then estimated national in-hospital influenza-associated mortality.
The median length of hospital stay for influenza pneumonia was
determined using data from all cases. The seasonal distribution of
influenza activity was plotted as a moving average of the monthly
proportion of influenza positive patients among all pneumonia
patients enrolled in the study.
Results
From January 2005 through December 2007, we enrolled
10,075 (50.1%) of 20,100 patients. Specifically, we enrolled 3,292
patients in 2005, 3,633 patients in 2006 and 3,150 patients in
2007. In 2008 when chest radiographs were no longer required for
eligibility, 13,425 patients were eligible and 50% were invited to
participate. Among 7,205 patients with a chest radiograph, 1,796
(24.9%) were enrolled and among 6,220 without a chest
radiograph, 1,248 (20.1%) were enrolled (Figure 2). Overall,
1,346 (10.3%) of enrolled clinical pneumonia patients tested
positive for influenza by RT-PCR or cell culture. Among the 1,346
pneumonia patients with influenza, 707 (52.5%) had results
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670 (60.9%; 37 missing) had evidence of pneumonia, including 40
of 387(5.9%; 21 missing) with consolidation and 327 of 393
(83.2%; 215 missing) with interstitial infiltrates.
In 2005, a year when Thailand’s National Influenza Center
(NIC) reported that influenza A (H3N2) virus strains predominat-
ed, 527 (16.0%) of 3,292 enrolled hospitalized pneumonia patients
tested positive for influenza. In this single year when both cell
culture and RTPCR were used to identify influenza virus, of 146
cell cultures that were influenza positive only 7 were not also PCR
positive. In 2006, influenza A (H1N1) virus strains predominated
and only 147 (4.1%) of 3,632 patients were influenza positive. In
2007, influenza type B and A (H3N2) viruses were approximately
equally represented and 243 (7.7%) of 3,150 patients tested
positive for influenza. In 2008 influenza type B predominated and
429 (14.1%) of 3,044 patients tested positive for influenza. In 2008,
Figure 1. Sa Kaeo and Nakhon Phanom Provinces in Thailand.
doi:10.1371/journal.pone.0007776.g001
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were influenza positive compared to 220 (18.1%) of 1,214 patients
who had not received a chest radiograph (p,0.0001).
The minimum incidence of hospitalized influenza pneumonia
with chest radiograph among all age groups was 42.1 per 100,000
persons in 2005, 11.7 per 100,000 in 2006, 19.1 per 100,000 in
2007 and 32.7 per 100,000 in 2008. In 2008, when patients both
with and without a chest radiograph were included, the minimum
incidence was 67 per 100,000. Children under 5 years of age and
adults over 65 years of age were most affected in each year. When
we adjusted for patients with a chest radiograph who were eligible
but were not enrolled, the estimated incidence of hospitalized
influenza pneumonia was to 83.3 per 100,000 persons in 2005,
21.7 per 100,000 in 2006, 41.6 per 100,000 in 2007, and 65.5 per
100,000 in 2008 (Figure 3). In 2008, when patients both with and
without a chest radiograph were included, the minimum incidence
was 134.4 per 100,000. When these incidences are applied to
Thailand’s national population, we estimate that nationwide at
least 73,413 and as many as 145,649 hospital admissions for
laboratory confirmed influenza pneumonia occurred between
January 2005 and December 2008 (Table 1).
During 2005, 2006 and 2008, pneumonia hospitalizations
associated with influenza A virus infections were greatest during
the months of June through October. In contrast, in 2007 a sharp
increase was observed during the months of January through
April. Influenza B virus infections did not demonstrate a consistent
seasonal pattern (Figure 4). Among 3,292 pneumonia cases in
2005, influenza A virus infections were identified in 372 (11.3%)
patients and influenza B virus infections were identified in 162
(4.9%) patients. In 2006, 92 (2.5%) influenza A virus infections
and 55 (1.5%) influenza B virus infections were identified among
3,633 pneumonia cases. In 2007, 210 (6.7%) influenza A virus
infections and 33 (1.1%) influenza B virus infections were
identified among 3,150 cases. In 2008, 238 (7.8%) influenza A
virus infections and 194 (6.4%) influenza B virus infections were
identified among 3,044 cases.
The incidence of influenza pneumonia was highest in children
less than 5 years of age and in adults greater than 60 years of age
during all years. Three hundred and sixty of 4,163 (8%)
pneumonia cases in children less than 5 and 117/503 (18.9%)
cases in children 5–9 years of age were influenza positive. Seven
hundred and two (52%) of all influenza pneumonia patients were
less than 15 years of age while 357 (26.5%) were 60 years of age or
older. The median length of hospital stay was 4 days for children
less than 1 year of age, 4 days for those over 60 years of age, and
4 days (range 0–42 days) across all age groups. Ten (0.75%)
Figure 2. Enrollment process.
doi:10.1371/journal.pone.0007776.g002
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doi:10.1371/journal.pone.0007776.g003
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patients older than 50 years of age.
Discussion
During 2005–2008, across all age groups influenza virus
infection was associated with 10.4% of pneumonia cases identified
in our study population. These findings extend our 2004 report in
which 80 (11%) of 761 pneumonia inpatients had laboratory-
confirmed influenza infection [15]. The annual adjusted incidence
of hospitalized influenza pneumonia across all age groups was 83,
22, 42 and 66 per 100,000 persons in 2005, 2006, 2007 and 2008,
respectively. For comparison, in 2004 we estimated an adjusted
incidence of hospitalized influenza pneumonia of 111 per 100,000
across all age groups in Sa Kaeo province [15]. The Thailand
MOPH passive surveillance system reported 4.8 cases of clinically
diagnosed influenza in hospitalized patients per 100,000 persons in
2005, 4.7 cases per 100,000 in 2006, and 5.7 cases per 100,000 in
2007 [30]. Using U.S. National Hospital Discharge Survey and
WHO laboratory data during 1979–2001, Thompson and
colleagues estimated that influenza was associated with 8.6% of
all primary pneumonia and influenza hospitalizations and the
average annual incidence across all age groups was 36.8 per
100,000 (range; 7.8–69.5)[31].
In temperate climates, major variations in influenza activity
from year to year have been well-documented [32,33]. Similarly,
substantial year-to-year variability in influenza activity occurs in
subtropical Thailand. We observed high levels of influenza activity
in 2005, mild activity in 2006, moderate activity in 2007 and high
levels of activity in 2008. According to virological surveillance
Table 1. Estimated Annual Influenza Pneumonia Hospital Admissions and In-Hospital Deaths in Thailand, 2005-2008.
YEAR ,15 years 15–50 years 50+ years Minimum Total Adjusted Total
Admissions Deaths Admissions Deaths Admissions Deaths Admissions Deaths Admissions Deaths
2008
2 7,833 22 3,675 18 12,205 197 23,713 237 47,196 481
2007
1 6,761 19 1,886 9 4,993 81 13,640 109 29,609 257
2006
1 4,897 14 1,156 6 1,839 30 7,892 49 14,209 92
2005
1 13,597 39 4,035 19 10,535 170 28,167 228 54,635 456
Total 33,088 95 10,753 52 29,572 477 73,413 623 145,649 1,287
Average 8,272 27 2,688 10 7,393 119 18,353 159 36,413 322
1Adjusted for patients who were eligible but who were not enrolled.
2As with 2005-2007, these estimates include only pneumonia patients with a chest radiograph.
doi:10.1371/journal.pone.0007776.t001
Figure 4. Seasonal distribution of influenza positive pneumonia 2005–2008. (n=1,346 influenza positive among 13,110 pneumonia cases).
doi:10.1371/journal.pone.0007776.g004
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personal communication May 2009), influenza A (H3N2) virus
strains predominated in 2005. This may explain in part the high
levels of influenza pneumonia activity seen in 2005 as influenza A
(H3N2) virus strains have been associated with a higher incidence
of severe and fatal influenza-attributable disease [34,35]. In 2006
and 2007 influenza A (H1N1) and influenza type B viruses co-
predominated while influenza type B viruses accounted for 50% of
all influenza viruses isolated by the Thai NIH during 2008. To our
knowledge, this is the first time such marked variability in
influenza pneumonia activity has been clearly documented in a
subtropical climate and the finding underscores the value of
collecting data during several consecutive years.
As observed in 2004, influenza type A activity in Thailand
increased sharply during the months of June through October in
both 2005 and 2006 [15]. However, this seasonal pattern was not
observed in 2007 when a sharp increase in influenza type A
activity was observed during January to April. In 2008, both
influenza A and B virus activity occurred throughout the year.
This finding illustrates the difficulty of effectively timing annual
vaccination campaigns in subtropical countries. Currently,
vaccination campaigns in Thailand are initiated in April and
May using Southern Hemisphere influenza vaccines. Our
observations suggest that additional approaches such as instituting
routine hospital-discharge influenza vaccination policies for
specific groups could be considered.
Our study has limitations that likely resulted in an underesti-
mation of the incidence of influenza pneumonia. Successful
identification of influenza virus in clinical specimens depends on
factors such as specimen quality, time from illness onset to
specimen collection, and optimal transportation and storage of
specimens prior to testing. These factors may have contributed to
under-ascertainment of influenza pneumonia in our study.
Further, we did not attempt to adjust for residents who sought
care for pneumonia outside of the study provinces [21,36] or,
during 2005–2007, for pneumonia patients who did not receive a
chest radiograph and were therefore excluded from the study.
These additional adjustments would likely have substantially
increased our incidence estimates.
We observed a nearly four-fold reduction in influenza-positive
pneumonia between 2005, a year in which influenza A (H3N2)
viruses predominated and 2006 when influenza A (H1N1) viruses
predominated. Influenza A (H1N1) infection may be less-often
associated with pneumonia. Alternatively, some influenza-positive
pneumonia cases may not have felt sufficiently ill to seek care at
the hospital. This potential detection bias may have caused us to
miss some influenza pneumonia cases and therefore underestimate
the disease burden. Finally, after modifying the enrollment criteria
in 2008 we observed that patients with clinical pneumonia who
had not received a chest radiograph were statistically significantly
more likely to be influenza positive. If this was also true during
2005–2007, then our adjustments that assumed the same rates of
influenza positivity in both groups (with and without chest
radiograph) substantially underestimated the burden of disease.
Our estimates of influenza-associated deaths do not include
deaths that were not associated with pneumonia. Thus, our
estimates of influenza pneumonia mortality are an underestima-
tion of total influenza-related deaths. Our study was also not
designed to ascertain influenza-associated deaths occurring in the
community following hospital discharge. Despite these limitations,
our estimates of influenza pneumonia in-hospital deaths are much
higher than figures reported by the national passive surveillance
system. For example, between 1999 and 2006 Thailand reported
just four deaths due to human influenza virus infection. This
under-ascertainment is likely explained by the lack of laboratory
diagnostic capacity for influenza in nearly all public hospitals and
to a perception among Thai clinicians that influenza is neither
common nor severe.
To calculate national estimates for influenza pneumonia
hospitalization, we extrapolated population-based data that
captured all pneumonia admissions from our two study provinces
(population 1.2 million) under the assumption that the incidence of
hospitalized influenza pneumonia does not differ systematically
year after year across the 76 provinces of Thailand. While we have
no evidence to suggest otherwise, if influenza activity did vary
systematically each year by province or geographic region within
Thailand, this could affect the accuracy of our national estimates.
Influenza associated in-hospital deaths were uncommon and the
extrapolation of small numbers to large populations can yield
unstable estimates. Regardless, we believe our mortality estimates
are conservative and represent an important starting point for
further research into this important aspect of disease burden.
Our study contributes to a growing body of published influenza
literature from Thailand [15,18,36]. Two studies from Thailand
reported that influenza virus is an important cause of chronic
obstructive pulmonary disease exacerbation and that influenza
vaccination is protective in these patients [37,38]. A 2006 study in
Thailand found that 8.6% of children admitted to the national
pediatric referral hospital with lower respiratory tract infection or
influenza-like illness had cell culture-confirmed influenza virus
infection and 80% had no known underlying diseases [39]. A
retrospective analysis of risk factors for influenza pneumonia in
Thailand found that underlying cardiovascular disease, respiratory
conditions and hospital admission in the preceding 12 months
were significant risk factors [40]. Finally, a study by Hanshaowor-
akul and colleagues reported that human influenza was identified
in 2,075 (18%) of 11,641 suspected avian influenza A(H5N1)
infections with 22 (1%) fatal cases, including seven deaths in
children less than ten years of age. In that report, 35% of
hospitalized human influenza infections had chest radiograph
confirmed pneumonia [41].
In conclusion, we estimated influenza disease burden during
four consecutive years using prospective, population-based sur-
veillance and RT-PCR laboratory confirmation in hospitalized
pneumonia patients in Thailand. We found evidence of a
substantial but variable incidence of influenza pneumonia mainly
affecting young children and the elderly. During 2005–2008,
influenza pneumonia resulted in an estimated average 36,413
hospital admissions and 322 in-hospital deaths each year. Our
findings support the continued development of a national control
strategy that extends influenza vaccination to young children and
improves access to antiviral medications. Data from other
Southeast Asian countries are needed to develop a better
understanding of the burden of disease, further describe the
contribution of influenza to childhood pneumonia, and to improve
regional pandemic preparedness by expanding national immuni-
zation program capacities in this region with large populations and
rapidly growing economies.
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